Alterations of cardiac α1-adrenoceptor subtypes in hypothyroid rats

Clinical and Experimental Pharmacology and Physiology

Volumn 24, Issue 7, 1997, Pages 481-486

  Zhang, Youyi ^a   Xu, Kaiming ^a   Han, Chide ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Heart; Hypothyroidism; mRNA; Subtypes; 1 Adrenoceptor

Indexed keywords

2 [2 (4 HYDROXYPHENYL)ETHYLAMINOMETHYL]TETRALONE I 125; 2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; 5 METHYLURAPIDIL; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; MESSENGER RNA; NIGULDIPINE; NORADRENALIN; PHENTOLAMINE MESYLATE; RADIOLIGAND; RECEPTOR SUBTYPE; THIOURACIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BINDING SITE; DRUG RECEPTOR BINDING; HEART; HEART MUSCLE CONTRACTILITY; HYPOTHYROIDISM; MALE; NONHUMAN; RAT; RECEPTOR AFFINITY; RECEPTOR DENSITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030954357     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1997.tb01231.x     Document Type: Article

References (48)

1. Zimmerman RS, Gharib H, Zimmeran D, Heublein D, Burnett JC Jr. Atrial natriuretie peptide in hypothyroidism. J. Clin. Endocrinol. Metab. 1987; 64: 353-5.
2. Dozin B, Magnuson MA, Nikodm VM. Thyroid hormone regulation of malic enzyme synthesis. J. Biol. Chem. 1986; 261: 10 290-2.
3. Segal J. Calcium is the first messenger for the action of thyroid hormone at the level of the plasma membrane: First evidence for an acute effect of thyroid hormone on calcium uptake in the heart. Endocrinology 1990; 126: 2693-702.
4. Klein I, Levey GS. New perspectives on thyroid hormones, catecholamines and the heart. Am. J. Med. 1984; 76: 167-72.
5. Klein I. Thyroid hormone and the cardiovascular system. Am. J. Med. 1984; 88: 631-7.
6. Polikar R, Kennedy B, Ziegler M, O'Connor T, Smith J, Nicod P. Plasma norepinephrine kinetics, dopamine-β-hydroxylase, and chromogranin-A, in hypothyroid patients before and following replacement therapy. J. Clin. Endocrinol. Metab. 1990; 70: 277-81.
7. Levey GS, Klein I. Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. Am. J. Med. 1990; 88: 642-6.
8. Polikar R, Buger AG, Scherrer U, Nicod P. The thyroid and the heart. Circulation 1993; 87: 1435-41.
9. Kunos G, Vermes-Kudos I, Nickerson M. Effects of thyroid state on adrenoceptor properties. Nature 1974; 250: 779-81.
10. Kunos G. Thyroid hormone-dependent interconversion of myocardial α- and β-adrenoceptors in the rat. Br. J. Pharmacol. 1977; 59: 177-89.
11. Kunos G, Mucci L, O'Regan S. The influence of hormonal and neuronal factors on rat heart adrenoceptors. Br. J. Pharmacol. 1980; 71: 371-86.
12. Fox AW, Juberg EN, May JM, Johnson RD, Abel PW, Minneman KP. Thyroid status and adrenergic receptor subtypes in the rat: Comparison of receptor density and responsiveness. J. Pharmacol. Exp. Ther. 1985; 235: 715-22.
13. 1d-adrenoceptor binding sites: Evidence for a subtype-specific regulation. Br. J. Clin. Pharmacol. 1990; 30: S125-7.
14. Limas C, Limas CJ. Influence of thyroid state on intracellular distribution of cardiac adrenoceptors. Circ. Res. 1987; 61: 824-8.
15. 3H-prazosin binding. Mol. Pharmacol. 1986; 29: 321-30.
16. 2+ in smooth muscle. Nature 1987; 329: 333-5.
17. 1-adrenergic receptors revealed by chlorethylconidine. Mol. Pharmacol. 1987; 32: 505-10.
18. 1-adrenergic receptor subtypes distinguished by chlorethylclonidine and WB4101. Mol. Pharmacol. 1988; 33: 509-14.
19. Gross G, Hanft G, Rugevics F. 5-Methyl-urapidil discriminates between subtypes of the α-adrenoceptors. Eur. J. Pharmacol. 1988; 151: 333-5.
20. 1-adrenoceptors. Eur. J. Pharmacol. 1989; 172: 131-45.
21. 2-adrenergic receptor mRNAs by thyroid state in the rat. J. Endocrinol. 1991; 129: 1116-18.
22. 1-adrenergic receptor. Proc. Natl Acad. Sci. USA 1988; 85: 7159-63.
23. 1-adrenergic receptor subtype. J. Biol. Chem. 1990; 265: 8183-9.
24. 1A-adrenergic receptor subtypes distinguished by chlorethylclonidine and WB4101. Mol. Pharmacol. 1991; 33: 509-14.
25. 1d-adrenergic receptor DNA. Mol. Pharmacol. 1991; 40: 876-83.
26. IUPHAR Committee of Receptor Nomenclature and Drug Classification. Receptor & Ion Channel Nomenclature Supplement. Trends Pharmacol. Sci. Nomenclature Suppl. 1995; 16: 9-12.
27. 1-adrenergic receptor subtypes in human tissues: implications for human-adrenergic physiology. Mol. Pharmacol. 1994; 45: 171-5.
28. 1D. Biochem. Biophys. Res. Commun. 1994; 200: 1177-84.
29. Chopra IJ. A radioimmunoassay for measurement of thyroxine in unextracted serum. J. Clin. Endocrinol. Metab. 1972; 34: 938-47.
30. 1-adrenoceptors. Eur. J. Pharmacol. 1981; 73: 221-4.
31. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal. Biochem. 1976; 72: 248-51.
32. Scatchard G. The attractions of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 1949; 51: 600-72.
33. Munson PJ, Rodbard D. LIGAND: A versatile computerized approach for characterization of ligand binding systems. Anal. Biochem. 1980; 107: 220-39.
34. i) and the concentration of inhibition which causes 50% inhibition of an enzymatic reaction. Biochem. Pharmacol. 1973; 22: 3099-108.
35. Chomzynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987; 162: 156-61.
36. Voigt MM, Kispert J, Chin H. Sequence of a rat brain cDNA encoding an alpha-1B adrenergic receptor. Nucleic Acids Res. 1990; 18: 1053.
37. 1A subtype. Mol. Pharmacol. 1994; 46: 414-22.
38. 1-adrenoceptor classification. Eur. J. Pharmacol. Mol. Pharmacol. 1994; 268: 141-9.
39. 1A subtype. Mol. Pharmacol. 1994; 46: 823-31.
40. 1-Adrenoceptor classification: Sharpening Occam's razor. Trends Pharmacol. Sci. 1994; 15: 167-70.
41. 1c-adrenoceptor: Studies in the isolated perfused kidney of rat. Br. J. Pharmacol. 1995; 115: 283-94.
42. 1-adrenoceptor: Consensus update. Pharmacol. Rev. 1995; 47: 267-70.
43. 1D subtype. Can. Physiol. Pharmacol. 1994; 72 (Suppl. 1): 323.
44. 1-adrenoceptors. Eur. J. Pharmacol. 1995; 272: R5-6.
45. 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline. Br. J. Pharmacol. 1995; 115: 981-6.
46. 1d-adrenoceptor subtype is involved in the noradrenaline-induced contractions of rat aorta. Life Sci. 1995; 57: PL159-63.
47. Piascik MT, Guarino RD, Smith MS, Soltis EE, Saussy DL Jr, Perez DM. The specific contribution of the novel alpha-1D adrenoceptor to the contraction of vascular smooth muscle. J. Pharmacol. Exp. Ther. 1996; 275: 1583-9.
48. Saussy DL Jr, Goetz AS, Queen KL, King HK, Lutz MW, Rimele TJ. Structure activity relationships of a series of buspirone analogs at alpha-1 adrenoceptors: Further evidence that rat aorta alpha-1 adrenoceptors are of the alpha-1D-subtype. J. Pharmacol. Exp. Ther. 1996; 278: 136-44.